I think UNI's product is far more superior, and hence you see its huge market cap right now.
The issue with UNI is whether they can mass produce. All things look good so far over at that end. They have set up a factory already recently.
RTL is highly speculative. They haven't lodged their patent yet, I think. But at 20 cents, definitely worth a gamble to some point. Their needle is easier to make and hence the cost of production should be cheaper.
RTL strategy of raising captial is very sound. They provide all exsiting shareholders with options (30 cents)and hence their shares won't be diluted. Now they got 8 million raised, and will sure to raise more capital in 3 months time.
I was thinking about buying more RTL, but I was on holiday so I missed the bargain at 24.5 cents. Well at least I will get some attractive options from my original issue.
